Elizabeth Singer

Title: Innovations of Elizabeth Singer

Introduction

Elizabeth Singer is a notable inventor based in Duarte, CA (US). She has made significant contributions to the field of biotechnology, particularly in her research related to the HER3 receptor and its interactions with heregulin. With a total of 2 patents, her work has implications for understanding and potentially treating various diseases.

Latest Patents

One of her latest patents focuses on methods and materials for characterizing and modulating the interaction between heregulin and HER3. This patent identifies and characterizes the domain in the HER3 receptor that interacts with the heregulin ligand. Typical embodiments of this invention include HER3 variant polypeptides that have amino acid sequences differing from the native HER3 polypeptide sequence, which exhibit altered affinities for heregulin. Additionally, the patent discloses methods and materials for identifying compounds that bind to the heregulin binding domain in HER3, as well as methods for modulating the interaction between HER3 and heregulin.

Career Highlights

Elizabeth Singer is affiliated with the University of California, where she conducts her research. Her work has been instrumental in advancing the understanding of receptor-ligand interactions, which are crucial for developing targeted therapies.

Collaborations

Some of her notable coworkers include Dennis J. Slamon and Ralf Landgraf, who have collaborated with her on various research projects.

Conclusion

Elizabeth Singer's innovative work in the field of biotechnology, particularly her patents related to HER3 and heregulin, showcases her significant contributions to science and medicine. Her research continues to pave the way for advancements in therapeutic strategies.